Clinical significance and determinants of the universal definition of perioperative bleeding classification in patients undergoing coronary artery bypass surgery

J Thorac Cardiovasc Surg. 2014 Oct;148(4):1640-1646.e2. doi: 10.1016/j.jtcvs.2014.07.040. Epub 2014 Jul 31.

Abstract

Objectives: We evaluated the clinical significance and identified the predictors of the universal definition of perioperative bleeding (UDPB) classes in patients undergoing isolated coronary artery bypass grafting (CABG).

Methods: Data on antithrombotic medication, perioperative bleeding, blood transfusion, and adverse events were available for 2764 patients who had undergone isolated CABG.

Results: The Papworth risk score correlated significantly with the UDPB classes (rate of UDPB class 3-4 and Papworth risk score of 0, 12.1%; 1, 23.9%; 2, 37.5%; and 3, 45.0%; P<.0001). Ordinal regression showed that increased age, female sex, low body mass index, low estimated glomerular filtration rate, low hemoglobin, dialysis, urgent or emergency operation, critical status, on-pump surgery, potent antiplatelet drug pause of <5 days, and warfarin pause of <2 days were independent predictors of high UDPB classes. These risk factors also predicted UDPB classes 3-4 in logistic regression analysis. Increasing UDPB classes were associated with an increased risk of in-hospital mortality (P=.002), stroke (P=.023), low cardiac output (P<.0001), prolonged use of inotropes (P<.0001), renal replacement therapy (P<.0001), length of stay in the intensive care unit (P<.0001), and late mortality (P<.0001) as assessed by multilevel propensity score-adjusted analysis. Similar findings were observed in the propensity score-adjusted analysis for the most severe grades of perioperative bleeding (ie, UDPB class 3-4).

Conclusions: High UDPB classes were associated with significantly poorer immediate and late outcomes. The UDPB classification seems to be a valuable research tool to estimate the severity of bleeding and its prognostic impact affect after coronary surgery.

MeSH terms

  • Anticoagulants / administration & dosage
  • Blood Loss, Surgical / prevention & control*
  • Coronary Artery Bypass*
  • Female
  • Hospital Mortality
  • Humans
  • Male
  • Postoperative Hemorrhage / classification*
  • Postoperative Hemorrhage / prevention & control*
  • Propensity Score
  • Risk Factors
  • Severity of Illness Index
  • Survival Rate

Substances

  • Anticoagulants